Cumberland Pharmaceuticals Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Cumberland Pharmaceuticals Inc. (CPIX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $2.27 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-07
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.27M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.38M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.49M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.61M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $2.27M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $2.49M 10-K · filed 2026-03-09 |
| 2025-09-30 | $2.61M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.73M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.85M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.97M 10-K · filed 2025-03-07 |
| 2024-09-30 | $3.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $3.23M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $3.36M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $3.49M 10-K · filed 2024-03-13 |
| 2023-09-30 | $3.62M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.76M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.56M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.67M 10-K · filed 2023-03-13 |
| 2022-09-30 | $13.40K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $21.17K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $34.11K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $52.10K 10-K · filed 2022-03-11 |
| 2021-09-30 | $83.04K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $110.77K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $143.20K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $180.21K 10-K · filed 2021-03-12 |
| 2020-09-30 | $229.70K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $275.53K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $325.62K 10-Q · filed 2020-05-22 |
| 2019-12-31 | $379.84K 8-K · filed 2020-12-10 |
| 2019-09-30 | $446.13K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $507.10K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $573.14K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |